Q: What are the therapeutic indications for Sildenafil Citrate Capsules?
A: Sildenafil Citrate is indicated primarily for the treatment of erectile dysfunction (ED) in adult males. At specific dosing regimens, it is also indicated for the treatment of Pulmonary Arterial Hypertension (PAH, WHO Group I) to improve exercise ability and delay clinical worsening.
Q: What is the mechanism of action of Sildenafil Citrate?
A: Sildenafil is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). By inhibiting PDE5 degradation of cGMP in the corpus cavernosum and the pulmonary vasculature, it promotes nitric oxide (NO)-mediated smooth muscle relaxation, vasodilation, and increased blood flow.
Q: What commercial strengths and pharmacopeial standards are available?
A: Sildenafil Citrate is supplied in hard gelatin capsules or liquid-filled/semi-solid soft gelatin capsules in standard strengths equivalent to 25 mg, 50 mg, and 100 mg of sildenafil base (as well as 20 mg for PAH indications), adhering to USP, BP, Ph. Eur., and IP specifications.
Q: What clinical advantage do capsule formulations provide over conventional tablets?
A: Capsule dosage forms (especially liquid-filled softgels or micro-granule capsules) provide rapid gastrointestinal disintegration, enhanced dissolution kinetics, faster systemic absorption, and masking of the bitter, astringent taste of sildenafil citrate salts without requiring extensive tablet-coating agents.
Q: What technical dossier support is provided for international health authority registration?
A: Comprehensive registration dossiers are available in CTD and ACTD formats (Modules 1–5), supported by WHO-GMP certification, Certificate of Pharmaceutical Product (COPP), batch-specific Certificates of Analysis (COA), Method of Analysis (MOA), Method Validation, Process Validation reports, and TSE/BSE-free gelatin capsule shell certification.
Q: What stability study documentation is available for global export markets?
A: Finished batches are validated with real-time and accelerated stability study data (40°C ± 2°C / 75% RH ± 5% RH) following ICH guidelines, fully qualified for Zone II, Zone IVa, and Zone IVb (hot and humid tropical export destinations).
Q: What packaging configurations are available for export and retail distribution?
A: Packaging options include moisture-barrier Alu-Alu blister packs, PVC/PVDC-Alu blister strips (such as 1×4, 1×10, and 10×10 unit-dose cartons), and induction-sealed HDPE bottles (30s, 60s, or 100s) fitted with tamper-evident caps, silica gel desiccants, and custom outer carton artwork.
Q: What is the standard commercial Minimum Order Quantity (MOQ) and production turnaround?
A: The standard commercial MOQ for export-branded and customized contract packaging is 100,000 to 200,000 capsules per strength. Manufacturing turnaround typically ranges from 45 to 60 days following confirmed regulatory artwork sign-off and commercial trade/payment clearance.
Q: Can you accommodate contract manufacturing (CDMO) and OEM private labeling?
A: Yes, contract manufacturing (CDMO), toll manufacturing, and private labeling services are supported. Services include custom capsule shell color coding, radial/axial strength and logo printing, multilingual carton localization, and GS1 2D datamatrix serialization.
Q: What are the recommended shelf-life and storage protocols for international transit?
A: Finished capsules offer a 24- to 36-month shelf life. Store below 25°C (excursions permitted up to 30°C) in a dry place shielded from heat, light, and moisture. Shipments to tropical destinations utilize rapid air cargo or temperature-monitored refrigerated sea containers (15–25°C reefers) to preserve shell integrity.
Q: What is the procedure for international importers to request commercial registration samples and analytical standards?
A: Packaged commercial samples, empty dummy cartons, batch COAs, active working standards, and impurity profiles are dispatched internationally via air courier upon receipt of a valid Drug Import Permit, Test License, or formal commercial Letter of Intent (LOI).
Tags:
@PharmaDistributors @MenHealthProcurement @HospitalSupplies @PharmaExporters @GlobalTenderSuppliers @CDMOPharma @UrologyFormulations
Hashtags: